September 2025

FDA approves Opzelura for atopic dermatitis in children

September 30, 2025 / Clinical Practice / InnovateMed Author / atopic dermatitis

by Lori Solomon edited by Stephanie Baum, reviewed by Robert Egan Editors’ notes The U.S. Food and Drug Administration has approved Opzelura cream 1.5% (ruxolitinib) for children ages 2 to 11 years with atopic dermatitis (AD). The approval is the first topical Janus kinase (JAK) inhibitor for the short-term, noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised […]

FDA approves Opzelura for atopic dermatitis in children Read More »

Biologic drug reduces symptoms and hospitalization for severe pulmonary hypertension after diagnosis in clinical trial

September 30, 2025 / Research update / InnovateMed Author / hypertension

by University of Michigan edited by Stephanie Baum, reviewed by Robert Egan Editors’ notes Credit: Unsplash/CC0 Public Domain Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension significantly reduces the likelihood of worsening disease when added within the first year after diagnosis, according to a study published in the New England Journal

Biologic drug reduces symptoms and hospitalization for severe pulmonary hypertension after diagnosis in clinical trial Read More »

Q&A: Is the medical community on the brink of a cure for Huntington’s disease?

September 30, 2025 / Research update / InnovateMed Author / Huntington’s disease

by Jane Kelly, University of Virginia edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes Credit: John DiJulio, University Communications Huntington’s disease is a fatal, hereditary neurological disorder mostly striking people between the ages of 30 and 50. In 1872, a young physician, Dr. George Huntington, first described the disease in detail. Since then, a cure has

Q&A: Is the medical community on the brink of a cure for Huntington’s disease? Read More »

Altering one area of the brain could rid alcohol withdrawal symptoms, study finds

September 30, 2025 / Research update / InnovateMed Author / withdrawal syndrome

by Devin Rokyta, Washington State University edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes Graphical abstract. Credit: Neuropharmacology (2025). DOI: 10.1016/j.neuropharm.2025.110595 By targeting a specific area of the brain, researchers at Washington State University may now hold the key to curbing the debilitating symptoms of alcohol withdrawal that push many people back to drinking. The new study found

Altering one area of the brain could rid alcohol withdrawal symptoms, study finds Read More »

Fat particles could be key to treating metabolic brain disorders

September 30, 2025 / Research update / InnovateMed Author / brain disorder

by University of Queensland edited by Lisa Lock, reviewed by Robert Egan Editors’ notes Hippocampal neurons (magenta), labelled for DDHD2 (cyan) and endomembranes (yellow). Credit: University of Queensland Evidence challenging the long-held assumption that neuronal function in the brain is solely powered by sugars has given researchers new hope of treating debilitating brain disorders. A University of Queensland

Fat particles could be key to treating metabolic brain disorders Read More »

Exercise can help to restore the immune system of people with post-COVID syndrome

September 30, 2025 / Research update / InnovateMed Author / post covid syndrome

by European Respiratory Society edited by Stephanie Baum, reviewed by Andrew Zinin Editors’ notes Credit: CC0 Public Domain Exercise can help to restore a more normal, well-regulated immune system in people with post-COVID syndrome, according to a gold-standard randomized-controlled trial presented at the European Respiratory Society Congress in Amsterdam, the Netherlands. The study was presented by Dr. Enya Daynes,

Exercise can help to restore the immune system of people with post-COVID syndrome Read More »

Advanced AI tool detects tiny brain lesions in children with epilepsy

September 30, 2025 / Research update / InnovateMed Author / epilepsy

by Murdoch Children’s Research Institute edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: Unsplash/CC0 Public Domain An advanced AI tool can detect tiny brain lesions that cause severe epilepsy in children, allowing faster diagnosis, more precise treatment and a potential cure, according to a new study. Developed by a team at Murdoch Children’s Research Institute

Advanced AI tool detects tiny brain lesions in children with epilepsy Read More »

Residential sulfur dioxide exposure linked to higher odds of amyotrophic lateral sclerosis onset

September 30, 2025 / Clinical Practice / InnovateMed Author / Amyotrophic Lateral Sclerosis

by Justin Jackson, Phys.org edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: CC0 Public Domain Université de Sherbrooke and Canadian collaborators report an association between long-term residential sulfur dioxide exposure and higher odds of amyotrophic lateral sclerosis (ALS) onset. ALS is a rare motor neuron disease with limited therapeutic options and substantial mortality within a

Residential sulfur dioxide exposure linked to higher odds of amyotrophic lateral sclerosis onset Read More »

Obesity genes tied to kidney, eye and nerve damage in diabetes

September 30, 2025 / Research update / InnovateMed Author / obesity genes

by Association of Basic Medical Sciences of FBIH edited by Gaby Clark, reviewed by Robert Egan Editors’ notes Credit: Biomolecules and Biomedicine (2025). DOI: 10.17305/bb.2025.11897 A large genome-wide analysis reports that common obesity traits share, and in some cases drive, risk for diabetic kidney disease, diabetic retinopathy, and diabetic neuropathy. The study maps shared DNA signals, tests causal links, and

Obesity genes tied to kidney, eye and nerve damage in diabetes Read More »

Cannabis extract shown to ease chronic lower back pain in high-quality clinical trial

September 30, 2025 / Research update / InnovateMed Author / chronic lower back pain

by Daniel Lawler edited by Andrew Zinin Editors’ notes While the trial suggests something in the cannabis plant can treat pain, that does not mean all marijuana has the same effect, researchers say. A specially developed cannabis extract relieves chronic lower back pain, according to a clinical trial published Wednesday that experts are calling the first

Cannabis extract shown to ease chronic lower back pain in high-quality clinical trial Read More »